公开(公告)号：EP1647269A1

公开(公告)日：2006-04-19

申请号：EP04738328.6

申请日：2004-07-02

申请人： Tianjin Tasly Pharmaceutical Co., Ltd., China

发明人： CHEN, Jianming No. 1 Liaohedong Road ,  YAN, Xijun No. 1 Liaohedong Road Xinyibai Avenue ,  YANG, Yuewu No. 1 Liaohedong Road Xinyibai Avenue ,  LU, Wenliang No. 1 Liaohedong Road ,  ZHU, Yonghong No. 1 Liaohedong Road ,  YE, Zhengliang No. 1 Liaohedong Road ,  WANG, Wei No. 1 Liaohedong Road Xinyibai Avenue ,  ZHU, Guoguang No. 1 Liaohedong Road ,  ZHENG, Zhigang No. 1 Liaohedong Road ,  WANG, Shuangming No. 1 Liaohedong Road

IPC分类号： A61K9/20 ,  A61K47/26 ,  A61K47/36 ,  A61K47/38 ,  A61K47/40

CPC分类号： A61K9/145 ,  A61K31/00 ,  A61K36/00

摘要： The present invention relates to the matrix adjuvants for drop pills and the preparation of the drop pills. The matrix adjuvants for drop pills of the present invention comprise new matrix adjuvants with or without the plastifying components, which are typically natural matrix adjuvants derived from plants and of safety and non-toxicity. The present invention decreases the toxicity caused by polyethylene glycol, alters the situation that adjuvants derived from animals is scarce, improves the quality of drop pills and accelerates the development of drop pills.

摘要翻译： 本发明涉及滴丸的基质佐剂和滴丸的制备。 用于本发明的滴丸的基质助剂包含具有或不具有塑化组分的新的基质佐剂，其通常是衍生自植物的天然基质佐剂并且具有安全性和无毒性。 本发明降低了由聚乙二醇引起的毒性，改变了来自动物的佐剂稀少的情况，提高了滴丸的质量，加速了滴丸的发展。